NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
Arch Biopartners Closes Non-Brokered Private Placement
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
Defence working to supply Accum to ADC companies
ROCKET DOCTOR AI INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE ALEA HEALTH HOLDINGS LTD.
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
Netramark signs four AI contracts with pharma company
Hemostemix Closes CDN$280,594 Private Placement
NervGen Pharma Announces US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
HLS gets approval for Nilemdo; Nezlizet needs more data
Light AI completes V1.0 diagnostic software system